CRMD - CorMedix - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRMD is currently covered by 5 analysts with an average price target of $16.97. This is a potential upside of $6.36 (59.94%) from yesterday's end of day stock price of $10.61.

CorMedix's activity chart (see below) currently has 58 price targets and 61 ratings on display. The stock rating distribution of CRMD is 94.44% BUY and 5.56% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.99% with an average time for these price targets to be met of 420.67 days.

Highest price target for CRMD is $20, Lowest price target is $17, average price target is $19.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 30-Jun-2025. First documented stock forecast 11-Dec-2018.

Currently out of the existing stock ratings of CRMD, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$15

3 months 16 days ago
(30-Jun-2025)

7/7 (100%)

$-1.56 (-9.42%)

92

Buy

$20

$9.27 (86.39%)

$13

3 months 16 days ago
(30-Jun-2025)

1/2 (50%)

$7.68 (62.34%)

60

Buy

$20

$9.27 (86.39%)

$15

3 months 22 days ago
(24-Jun-2025)

14/17 (82.35%)

$4.28 (27.23%)

353

Buy

$17

$6.27 (58.43%)

$12

3 months 26 days ago
(20-Jun-2025)

5/6 (83.33%)

$3.39 (24.91%)

171

Buy

1 years 11 months ago
(15-Nov-2023)

0/1 (0%)

$8.28 (70.65%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRMD (CorMedix) average time for price targets to be met?

On average it took 420.67 days on average for the stock forecasts to be realized with a an average price target met ratio 56.99

Which analyst has the current highest performing score on CRMD (CorMedix) with a proven track record?

JASON BUTLER

Which analyst has the current lower performing score on CRMD (CorMedix) with a proven track record?

BRANDON FOLKES

Which analyst has the most public recommendations on CRMD (CorMedix)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on CRMD

Which analyst is the currently most bullish on CRMD (CorMedix)?

Brandon Folkes with highest potential upside - $9.27

Which analyst is the currently most reserved on CRMD (CorMedix)?

James Lee with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?